Company Search:
Advanced Search
Sponsored Links
Sopharma AD Company Snapshot
Sopharma AD operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other pharmaceutical manufacturers in Europe: Recipharm AB (publ) of Sweden (2017 sales of 5.33 billion Swedish Kronor [US$630.39 million] ), Boiron SA of France (617.54 million Euro [US$757.72 million] ), and Swedish Orphan Biovitrum AB (publ) which is based in Sweden (6.51 billion Swedish Kronor [US$769.78 million] of which 100% was Sales of Pharmaceuticals).

Sales Analysis. Sopharma AD reported sales of 1.02 billion Bulgarian Lev (US$642.69 million) for the year ending December of 2017. This represents an increase of 15.7% versus 2016, when the company's sales were 885.38 million Bulgarian Lev.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sopharma AD
  Stock Performance Chart for Sopharma AD
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 4.20
(Figures in Bulgarian Lev)
1 Week -0.2%   13 Weeks 1.0%  
4 Weeks -1.4%   52 Weeks 2.4%  
Sopharma AD Key Data:
  Ticker: 3JR Country: Bulgaria
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,024,457,000
(Year Ending Jan 2018).
Employees: 4,543
  Currency: Bulgarian Lev Market Cap: 528,212,660
  Fiscal Yr Ends: December Shares Outstanding: 125,764,919
  Share Type: Closely Held Shares: 71,616,388
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.